Sleep-Disordered Breathing among Newborns with Myelomeningocele - 23/02/18
Doi : 10.1016/j.jpeds.2017.10.070
Renée A. Shellhaas, MD, MS 1, 2, * 
, Payal V. Kenia, MD 1, Fauziya Hassan, MD, MS 1, 2, John D.E. Barks, MD 1, Niko Kaciroti, PhD 1, Ronald D. Chervin, MD, MS 2, 3
, Payal V. Kenia, MD 1, Fauziya Hassan, MD, MS 1, 2, John D.E. Barks, MD 1, Niko Kaciroti, PhD 1, Ronald D. Chervin, MD, MS 2, 3 1 Department of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, MI
2 Sleep Disorders Center, University of Michigan, Ann Arbor, MI
3 Department of Neurology, University of Michigan, Ann Arbor, MI
*Reprint requests: Renée A. Shellhaas, MD, MS, University of Michigan, Pediatric Neurology, CS Mott Children's Hospital, Room 12-733 1540 E. Hospital Dr, Ann Arbor, MI 48109-4279.University of MichiganPediatric NeurologyCS Mott Children's HospitalRoom 12-733 1540 E. Hospital DrAnn ArborMI48109-4279
Abstract |
In a matched cohort study, we report that the apnea-hypopnea index is significantly higher in neonates with myelomeningocele (34 ± 22) compared with age-matched controls (19 ± 11; P = .021). Assessment of newborns with myelomeningocele for sleep-disordered breathing may facilitate early treatment; the impact on long-term neurodevelopment is unknown.
Le texte complet de cet article est disponible en PDF.Keywords : polysomnography, obstructive sleep apnea, central sleep apnea, spina bifida, neonatal
Abbreviations : AHI, NICU, SDB
Plan
| Supported by the American Sleep Medicine Foundation (to R.S.), the National Institutes of Health (NIH) (R21HD083409 and K23HD068402 to R.S.), and the University of Michigan Barwick Scholar Award (to R.S.). R.S. receives research support from the Patient-Centered Outcomes Research Institute, the NIH, the Pediatric Epilepsy Research Foundation, the American Sleep Medicine Foundation, and the University of Michigan. R.S. serves on the Board of the Child Neurology Society and on the Steering Committee of the Pediatric Epilepsy Research Consortium and receives royalties from UpToDate. R.C. serves on the Board of the American Academy of Sleep Medicine and receives royalties from UpToDate. The other authors declare no conflicts of interest. |
|
| Portions of this study were presented as an abstract at the Pediatric Academic Societies Meeting, May 6-9, 2017, San Francisco, California and the 31st Annual Meeting of the Associated Professional Sleep Societies, LLC, June 3-7, 2017, Boston, Massachusetts. |
© 2017
Elsevier Inc. Tous droits réservés.
Vol 194
P. 244 - mars 2018 Retour au numéro
Article précédent
- Pyridostigmine for the Reversal of Severe Adverse Reactions to Botulinum Toxin in Children
- Ryan M. Boerner, David L. Young, Sharon H. Gnagi, David R. White, Lucinda A. Halstead
- Heterozygous Deletion Impacting SMARCAD1 in the Original Kindred with Absent Dermatoglyphs and Associated Features (Baird, 1964)
- Xiao Chang, Dong Li, Lifeng Tian, Yichuan Liu, Michael March, Tiancheng Wang, Cuiping Hou, Renata Pellegrino, Richard Levy, Melinda Jen, Raymond Soccio, Patrick Sleiman, Hakon Hakonarson, Leslie Castelo-Soccio
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?